دورية أكاديمية
أعرض في EDS

Oligoclonal CD4 + CXCR5 + T cells with a cytotoxic phenotype appear in tonsils and blood.

التفاصيل البيبلوغرافية
العنوان: Oligoclonal CD4 + CXCR5 + T cells with a cytotoxic phenotype appear in tonsils and blood.
المؤلفون: Liang C; Functional Genomics and Systems Biology Group, Department of Bioinformatics, Biocenter, Julius-Maximilians-University Würzburg, Würzburg, Germany.; Institute of Immunology, Jena University Hospital, Friedrich-Schiller-University, Jena, Germany., Spoerl S; Department of Internal Medicine 5, Hematology/Oncology, University Hospital Erlangen, Friedrich-Alexander-University Erlangen-Nürnberg (FAU), Comprehensive Cancer Center Erlangen-EMN, Erlangen, Germany., Xiao Y; Institute of Pathology, Julius-Maximilians-University Würzburg, Würzburg, Germany., Habenicht KM; Division of Genetics, Department Biology, Nikolaus-Fiebiger-Center of Molecular Medicine, Friedrich-Alexander University Erlangen-Nürnberg, Erlangen, Germany., Haeusl SS; Institute of Pathology, Julius-Maximilians-University Würzburg, Würzburg, Germany., Sandner I; Department of Internal Medicine 5, Hematology/Oncology, University Hospital Erlangen, Friedrich-Alexander-University Erlangen-Nürnberg (FAU), Comprehensive Cancer Center Erlangen-EMN, Erlangen, Germany., Winkler J; Department of Internal Medicine 5, Hematology/Oncology, University Hospital Erlangen, Friedrich-Alexander-University Erlangen-Nürnberg (FAU), Comprehensive Cancer Center Erlangen-EMN, Erlangen, Germany., Strieder N; Leibniz Institute for Immunotherapy, Regensburg, Germany., Eder R; Department of Internal Medicine III, University Hospital Regensburg, Regensburg, Germany., Stanewsky H; Leibniz Institute for Immunotherapy, Regensburg, Germany., Alexiou C; Department of Otorhinolaryngology, Head & Neck Surgery, Else Kröner-Fresenius-Foundation-Professorship, Section of Experimental Oncology & Nanomedicine (SEON), University Hospital Erlangen, Friedrich-Alexander University Erlangen-Nürnberg, Erlangen, Germany., Dudziak D; Laboratory of Dendritic Cell Biology, Department of Dermatology, University Hospital Erlangen, Friedrich-Alexander University of Erlangen-Nürnberg, Erlangen, Germany.; Institute of Immunology, Jena University Hospital, Friedrich-Schiller-University, Jena, Germany., Rosenwald A; Institute of Pathology, Julius-Maximilians-University Würzburg, Würzburg, Germany.; Comprehensive Cancer Centre Mainfranken, Julius-Maximilians-University of Würzburg, Würzburg, Germany., Edinger M; Leibniz Institute for Immunotherapy, Regensburg, Germany.; Department of Internal Medicine III, University Hospital Regensburg, Regensburg, Germany., Rehli M; Leibniz Institute for Immunotherapy, Regensburg, Germany.; Department of Internal Medicine III, University Hospital Regensburg, Regensburg, Germany., Hoffmann P; Leibniz Institute for Immunotherapy, Regensburg, Germany.; Department of Internal Medicine III, University Hospital Regensburg, Regensburg, Germany., Winkler TH; Division of Genetics, Department Biology, Nikolaus-Fiebiger-Center of Molecular Medicine, Friedrich-Alexander University Erlangen-Nürnberg, Erlangen, Germany., Berberich-Siebelt F; Institute of Pathology, Julius-Maximilians-University Würzburg, Würzburg, Germany. path230@mail.uni-wuerzburg.de.
المصدر: Communications biology [Commun Biol] 2024 Jul 18; Vol. 7 (1), pp. 879. Date of Electronic Publication: 2024 Jul 18.
نوع المنشور: Journal Article
اللغة: English
بيانات الدورية: Publisher: Nature Publishing Group UK Country of Publication: England NLM ID: 101719179 Publication Model: Electronic Cited Medium: Internet ISSN: 2399-3642 (Electronic) Linking ISSN: 23993642 NLM ISO Abbreviation: Commun Biol Subsets: MEDLINE
أسماء مطبوعة: Original Publication: London, United Kingdom : Nature Publishing Group UK, [2018]-
مواضيع طبية MeSH: Palatine Tonsil*/immunology , Palatine Tonsil*/metabolism , Palatine Tonsil*/cytology , Receptors, CXCR5*/metabolism , Receptors, CXCR5*/genetics, Humans ; Phenotype ; CD4-Positive T-Lymphocytes/immunology ; CD4-Positive T-Lymphocytes/metabolism ; Male ; Female ; Adult
مستخلص: In clinical situations, peripheral blood accessible CD3 + CD4 + CXCR5 + T-follicular helper (T FH ) cells may have to serve as a surrogate indicator for dysregulated germinal center responses in tissues. To determine the heterogeneity of T FH cells in peripheral blood versus tonsils, CD3 + CD4 + CD45RA - CXCR5 + cells of both origins were sorted. Transcriptomes, TCR repertoires and cell-surface protein expression were analysed by single-cell RNA sequencing, flow cytometry and immunohistochemistry. Reassuringly, all blood-circulating CD3 + CD4 + CXCR5 + T-cell subpopulations also appear in tonsils, there with some supplementary T FH characteristics, while peripheral blood-derived T FH cells display markers of proliferation and migration. Three further subsets of T FH cells, however, with bona fide T-follicular gene expression patterns, are exclusively found in tonsils. One additional, distinct and oligoclonal CD4 + CXCR5 + subpopulation presents pronounced cytotoxic properties. Those 'killer T FH (T FK ) cells' can be discovered in peripheral blood as well as among tonsillar cells but are located predominantly outside of germinal centers. They appear terminally differentiated and can be distinguished from all other T FH subsets by expression of NKG7 (TIA-1), granzymes, perforin, CCL5, CCR5, EOMES, CRTAM and CX3CR1. All in all, this study provides data for detailed CD4 + CXCR5 + T-cell assessment of clinically available blood samples and extrapolation possibilities to their tonsil counterparts.
(© 2024. The Author(s).)
References: Immunity. 2022 Feb 8;55(2):272-289.e7. (PMID: 35081372)
Curr Opin Virol. 2020 Oct;44:162-168. (PMID: 33039898)
Eur J Immunol. 2012 Aug;42(8):1981-8. (PMID: 22730020)
Immunity. 2013 Mar 21;38(3):596-605. (PMID: 23499493)
Cell Metab. 2022 Apr 5;34(4):516-532.e11. (PMID: 35316657)
Trends Immunol. 2014 Sep;35(9):436-42. (PMID: 24998903)
PLoS Pathog. 2011 Jul;7(7):e1002098. (PMID: 21814510)
Int J Mol Sci. 2021 Aug 05;22(16):. (PMID: 34445118)
Immunity. 2011 Jan 28;34(1):108-21. (PMID: 21215658)
Nat Commun. 2022 Feb 10;13(1):805. (PMID: 35145086)
Nat Immunol. 2019 Feb;20(2):163-172. (PMID: 30643263)
Nat Rev Immunol. 2020 Feb;20(2):128-136. (PMID: 31591533)
Nature. 2018 Aug;560(7719):494-498. (PMID: 30089906)
Nat Immunol. 2015 Feb;16(2):142-52. (PMID: 25594465)
Eur J Immunol. 2003 Feb;33(2):474-82. (PMID: 12645946)
Nat Rev Immunol. 2022 Sep;22(9):567-575. (PMID: 35277664)
Front Immunol. 2011 Aug 30;2:36. (PMID: 22566826)
Immunity. 2021 Apr 13;54(4):702-720.e17. (PMID: 33789089)
Eur J Immunol. 2006 Jul;36(7):1892-903. (PMID: 16791882)
Nature. 2021 May;593(7860):506-509. (PMID: 34035530)
J Immunol. 2011 May 15;186(10):5556-68. (PMID: 21471443)
Database (Oxford). 2019 Jan 1;2019:. (PMID: 30951143)
Proc Natl Acad Sci U S A. 2021 Mar 16;118(11):. (PMID: 33836594)
J Clin Invest. 2014 Dec;124(12):5191-204. (PMID: 25347469)
Immunity. 2013 Oct 17;39(4):758-69. (PMID: 24035365)
Nat Immunol. 2015 Sep;16(9):980-90. (PMID: 26214741)
JCI Insight. 2019 Aug 22;4(16):. (PMID: 31434804)
Proc Natl Acad Sci U S A. 2015 Jan 27;112(4):1125-30. (PMID: 25583478)
Trends Immunol. 2021 Apr;42(4):336-349. (PMID: 33663954)
Sci Rep. 2018 Feb 23;8(1):3529. (PMID: 29476109)
Nat Med. 2011 Jul 24;17(8):983-8. (PMID: 21785430)
Nat Immunol. 2011 Jun;12(6):536-43. (PMID: 21572431)
Annu Rev Immunol. 2016 May 20;34:335-68. (PMID: 26907215)
Cell. 2020 Nov 25;183(5):1340-1353.e16. (PMID: 33096020)
J Exp Med. 2000 Dec 4;192(11):1553-62. (PMID: 11104798)
Transplant Proc. 2004 Mar;36(2 Suppl):367S-371S. (PMID: 15041370)
Sci Immunol. 2017 Sep 8;2(15):. (PMID: 28887367)
Cell. 2021 Jun 24;184(13):3573-3587.e29. (PMID: 34062119)
Immunity. 2014 Apr 17;40(4):569-81. (PMID: 24745333)
Sci Immunol. 2023 Apr 14;8(82):eade8162. (PMID: 37027481)
J Immunol. 2016 Aug 1;197(3):983-93. (PMID: 27342848)
Front Immunol. 2020 Jan 15;10:3090. (PMID: 32010141)
Science. 2009 Aug 21;325(5943):1006-10. (PMID: 19608860)
Nat Methods. 2012 Jun 28;9(7):676-82. (PMID: 22743772)
Immunity. 2019 Nov 19;51(5):826-839.e5. (PMID: 31732165)
BMC Bioinformatics. 2021 Sep 10;22(1):433. (PMID: 34507520)
Immunity. 2013 Oct 17;39(4):770-81. (PMID: 24138884)
Front Immunol. 2022 Jan 06;12:791100. (PMID: 35069572)
Nat Immunol. 2013 Mar;14(3):281-9. (PMID: 23334788)
J Immunol Methods. 2003 Oct 1;281(1-2):65-78. (PMID: 14580882)
Eur J Immunol. 2009 Mar;39(3):695-703. (PMID: 19197944)
J Exp Med. 2014 Mar 10;211(3):545-61. (PMID: 24590764)
Science. 2013 Aug 9;341(6146):673-7. (PMID: 23887872)
J Cell Physiol. 2019 Dec;234(12):22477-22484. (PMID: 31119756)
J Exp Med. 2016 Jan 11;213(1):123-38. (PMID: 26694968)
Science. 2021 Jul 16;373(6552):. (PMID: 34437125)
Nature. 2000 Jul 20;406(6793):309-14. (PMID: 10917533)
Nat Immunol. 2014 Oct;15(10):957-64. (PMID: 25194422)
Eur J Immunol. 2021 Apr;51(4):848-863. (PMID: 33345332)
J Immunol. 2018 Sep 1;201(5):1359-1372. (PMID: 30030323)
Int Immunopharmacol. 2015 Oct;28(2):841-5. (PMID: 25899083)
Immunity. 2018 Aug 21;49(2):264-274.e4. (PMID: 30076099)
J Exp Med. 2015 Feb 9;212(2):217-33. (PMID: 25646266)
J Immunol. 2016 Mar 1;196(5):2015-9. (PMID: 26851216)
Nat Commun. 2016 Jan 28;7:10579. (PMID: 26818004)
J Exp Med. 2000 Dec 4;192(11):1545-52. (PMID: 11104797)
Proc Natl Acad Sci U S A. 2017 Aug 1;114(31):E6400-E6409. (PMID: 28698369)
Int Immunol. 2016 Apr;28(4):173-9. (PMID: 26714592)
J Exp Med. 2006 Dec 25;203(13):2865-77. (PMID: 17158960)
Cancer Immunol Res. 2022 Jul 1;10(7):885-899. (PMID: 35587532)
Nat Immunol. 2010 Feb;11(2):114-20. (PMID: 20084069)
PLoS Comput Biol. 2018 Nov 28;14(11):e1006571. (PMID: 30485278)
Immunol Rev. 2018 May;283(1):99-112. (PMID: 29664577)
J Immunol. 2011 Nov 1;187(9):4553-60. (PMID: 21984700)
Sci Adv. 2019 Dec 11;5(12):eaaw1715. (PMID: 31844658)
Sci Immunol. 2021 May 28;6(59):. (PMID: 34049865)
Immunol Cell Biol. 2014 Jan;92(1):57-63. (PMID: 24189164)
FEBS J. 2018 Aug;285(16):2944-2971. (PMID: 29637711)
Cell Immunol. 2010;262(2):89-95. (PMID: 20236628)
Oncotarget. 2016 Nov 22;7(47):77444-77456. (PMID: 27764808)
Cell Mol Immunol. 2021 Mar;18(3):523-527. (PMID: 32868910)
Immunity. 2019 May 21;50(5):1132-1148. (PMID: 31117010)
J Biomed Biotechnol. 2011;2011:954602. (PMID: 22174559)
J Immunol. 2004 Jul 1;173(1):68-78. (PMID: 15210760)
PLoS Pathog. 2014 Jan 30;10(1):e1003853. (PMID: 24497824)
Cell Rep. 2020 Oct 6;33(1):108232. (PMID: 33027650)
Proc Natl Acad Sci U S A. 2015 Aug 4;112(31):E4256-63. (PMID: 26195744)
Annu Rev Immunol. 2012;30:69-94. (PMID: 22149932)
Sci Transl Med. 2019 Feb 6;11(478):. (PMID: 30728285)
Nat Med. 2011 Jul 24;17(8):975-82. (PMID: 21785433)
Bioinformatics. 2017 Aug 01;33(15):2424-2426. (PMID: 28369169)
Nat Immunol. 2020 Oct;21(10):1205-1218. (PMID: 32839608)
EMBO J. 2016 Apr 15;35(8):881-98. (PMID: 26957522)
معلومات مُعتمدة: 324392634 Deutsche Forschungsgemeinschaft (German Research Foundation); FOR2830 Deutsche Forschungsgemeinschaft (German Research Foundation); BE2309/8-1 Deutsche Forschungsgemeinschaft (German Research Foundation); DU548/5-1 420943261 Deutsche Forschungsgemeinschaft (German Research Foundation)
المشرفين على المادة: 0 (Receptors, CXCR5)
0 (CXCR5 protein, human)
تواريخ الأحداث: Date Created: 20240718 Date Completed: 20240718 Latest Revision: 20240819
رمز التحديث: 20240819
مُعرف محوري في PubMed: PMC11258247
DOI: 10.1038/s42003-024-06563-1
PMID: 39025930
قاعدة البيانات: MEDLINE
الوصف
تدمد:2399-3642
DOI:10.1038/s42003-024-06563-1